Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses.
Ellis M, Davis N, Coop A, Liu M, Schumaker L, Lee RY, Srikanchana R, Russell CG, Singh B, Miller WR, Stearns V, Pennanen M, Tsangaris T, Gallagher A, Liu A, Zwart A, Hayes DF, Lippman ME, Wang Y, Clarke R
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine if biopsy specimens preserved by snap freezing or with RNAlater differ with regard to the quantity and quality of extracted RNA or gene expression profiles.
Summary of Findings
There was no significant difference between the quantity of RNA extracted from snap frozen and RNAlater preserved specimens. More than 90% of the 55 biopsies assessed yielded high quality RNA as determined by a bioanalyzer and lab-on-a-chip technology; the authors did not note any preservation-dependent effects. Microarray analysis of cancerous and noncancerous breast cancer biopsies resulted in a linear separation of profiles based upon diagnosis, which was not influenced by specimen preservation method.
Biospecimens
TissueBreastPreservation Types
RNAlaterFrozenDiagnoses
NeoplasticCarcinomaNormalPlatforms
RNADNA microarrayRNAAutomated electrophoresis/BioanalyzerRNASpectrophotometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Breast cancerNo breast cancerBiospecimen Preservation Type of fixation/preservation RNAlaterSnap frozen